Pharmaceutical Technology

MAY 23, 2023

The global pharmaceutical industry experienced a 23% decline in the number of environmental sustainability-related patent applications in Q1 2023 compared with the previous quarter. The total number of environmental sustainability-related grants dropped by 24% in Q1 2023, according to GlobalData’s Patent Analytics. Buy the report here.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

STAT

FEBRUARY 28, 2023

Although investors now judge more and more businesses on their environmental, social and governance (ESG) performance, a 2021 analysis showed that only 0.2% of companies around the world were strongly aligned with the United Nations Sustainable Development Goals.

97

97

STAT

DECEMBER 8, 2022

“We need to put this as a challenge to the CEOs and think about the environmental, social, and governance aspects of this as well.” ” Read the rest…

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

Pharmaceutical Technology

JULY 19, 2022

All aspects of environmental, social, and governance (ESG) are important, and in the healthcare industry, companies must excel across all three. Companies from across the healthcare industry widely promote their corporate social activities and improving their environmental rating is top of many corporate agendas.

Hospitals 64

Hospitals Vaccines 64

Pharmaceutical Technology

MAY 9, 2023

The global pharmaceutical industry experienced a 114% rise in company filings mentions of environmental sustainability in Q1 2023 compared with the previous quarter, with the highest share accounted for by Novozymes with 27% year-on-year increase, according to GlobalData’s analysis of over 757 pharmaceutical company filings.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies 40

Pharmaceutical Technology

JULY 21, 2022

The pharma industry has deeply rooted environmental, social, and governance (ESG) issues that challenge sustainability. For pharma and medical device companies, 3D printing can reduce costs, waste, and the environmental burden. 3D printing.

Hospitals 98

Hospitals FDA 98

PharmExec

AUGUST 11, 2022

The pharma industry is beginning to perform better with environmental, social, and governance (ESG).

52

52

Pharmaceutical Technology

MAY 9, 2023

The global pharmaceutical industry experienced a 141% rise in company filings mentions of corporate governance in Q1 2023 compared with the previous quarter, with the highest share accounted for by GSK with 306% year-on-year increase, according to GlobalData’s analysis of over 898 pharmaceutical company filings. Buy the report here.

Pharmaceutical Companies 45

Pharmaceutical Companies Pharmaceutical Companies 45

European Pharmaceutical Review

JULY 12, 2022

According to a recent survey of patient groups, Roche, Pfizer, ViiV Healthcare and Gilead Sciences are among the top companies for implementing and reporting progress on environmental, social, governance (ESG) activities.

Communication 99

Communication 99

Pharmaceutical Technology

MAY 9, 2023

The global pharmaceutical industry experienced a 141% rise in company filings mentions of corporate governance in Q1 2023 compared with the previous quarter, with the highest share accounted for by GSK with 306% year-on-year increase, according to GlobalData’s analysis of over 898 pharmaceutical company filings. Buy the report here.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies 40

European Pharmaceutical Review

JULY 5, 2022

After more than 20 years of environmental action, Pfizer has committed to further reduce its greenhouse gas (GHG) emissions and aims to achieve the voluntary Net-Zero Standard by 2040 – a full 10 years ahead of the standard’s proposed timeline. WHClimatePledge. — Pfizer Inc. pfizer) June 30, 2022.

Pharmaceutical Companies 110

Pharmaceutical Companies Pharmaceutical Companies Hospitals 110

Pharma Marketing Network

DECEMBER 17, 2021

Step one is to assess your corporate social responsibility (CSR) policies and ensure actions are integrated across the organization. A CSR assessment can be useful to differentiate the company when engaging new clients or recruiting socially conscious job candidates. Social impact is also high on the list.

Pharmaceutical Companies 103

Pharmaceutical Companies Pharmaceutical Companies Communication 103

pharmaphorum

NOVEMBER 3, 2022

Blakeney will explore ‘Business and social action’, another talk from Digital Catapult discusses ‘Enabling the twin transition through building sustainable supply chains: why, what, and how’, and One Young World holds forth on ‘Environmental, social, and corporate governance (ESG)-led growth: Building a thriving stakeholder economy’.

88

88

European Pharmaceutical Review

JULY 15, 2022

In addition to the environmental benefits of reducing carbon emissions, a sustainable energy strategy has financial implications too. The four governments of the UK established the scheme to increase the climate ambition of the UK’s carbon pricing policy, whilst also protecting the competitiveness of UK businesses.

Pharmaceutical Companies 94

Pharmaceutical Companies Pharmaceutical Companies 94

PharmExec

SEPTEMBER 2, 2022

The report details the company's efforts environmental, social, and governance areas.

40

40

Pharmaceutical Technology

JULY 21, 2022

As part of ESG (Environmental, Social, and Governance), the social good delivered by robust healthcare systems are at the core of healthy populations. Healthcare has not yet come under as much environmental scrutiny as other industries. Healthy and safe citizens are critical to functioning economies.

Vaccines 52

Vaccines 52

European Pharmaceutical Review

JANUARY 2, 2024

Nevertheless, this may limit the revenue growth for pharma, with production costs on the rise: for example, due to suppliers rising the costs and employees expecting pay rises, drug production costs may increase well above inflation rates,” Jakimaviciute asserted.

80

80

Pharmaceutical Technology

DECEMBER 16, 2022

The pharmaceutical industry must improve its environmental footprint by investing in technology and expertise, as well as through better design of new drugs early in their development, according to a GlobalData survey of the pharmaceutical industry.

64

64

European Pharmaceutical Review

AUGUST 11, 2022

The Frost & Sullivan Institute stated that it is proud to present Samsung Biologics with the 2022 Enlightened Growth Leadership Award for not only demonstrating growth excellence but also social responsibility. It considers the synergy between growth, corporate social responsibility (CSR) and ESG.

Vaccines 104

Vaccines 104

Pharmaceutical Technology

MAY 1, 2023

Also, this month’s thematic take digs into the varied facets of Environmental, Social and Governance (ESG)-related issues in the pharmaceutical industry. Don’t miss an exclusive interview looking at the progress made in the decade since the first chimeric antigen receptor (CAR)-T therapy was successfully tested in a patient.

Vaccines 52

Vaccines 52

Pharma Mirror

AUGUST 28, 2021

Highlights & rationale– The report showcases Azelis’ environmental, social, and governance (ESG) commitments and reinforces its ambitions to become the world-leading provider of sustainable solutions and services– Azelis sustainability strategy, Action 2025, is built upon four pillars: People, Products and Innovation, Governance (..)

52

52

European Pharmaceutical Review

JANUARY 12, 2023

Sanofi received the SMI’s Terra Carta Seal award for leadership in environmental, social, and corporate governance (ESG). The company stated its environmental management strategy outlines a number of core activities to reduce emissions, including: Process energy optimisation. Samsung Biologics.

Pharmaceutical Companies 95

Pharmaceutical Companies Pharmaceutical Companies 95

Hospital Pharmacy Europe

DECEMBER 19, 2023

Alongside this, COP28 saw finance announcements made by stakeholders including governments, development banks, multilateral institutions, philanthropies and non-governmental organisations to expand their investments in climate and health solutions.

Hospitals 52

Hospitals 52

Pharmaceutical Technology

OCTOBER 26, 2022

Over recent years, many pharmaceutical companies have taken up environment, social and governance (ESG) targets in order to prioritize sustainability whilst boosting their external public relations. Reaching social and governance goals. GlobalData is the parent company of Pharmaceutical Technology.

Insurance Coverage 64

Insurance Coverage Pharmaceutical Companies Pharmaceutical Companies Insurance 64

Fuld

AUGUST 10, 2023

The past five years have seen significant progress in raising global awareness of environmental, social, and governance (ESG) issues, leading to its increased prioritization by consumers, investors, and regulators. Governments are expected to include these in their policies to make economies more sustainable.

Documentation 52

Documentation 52

Fuld

NOVEMBER 13, 2023

We then examine the integral role of Environmental, Social, and Governance (ESG) principles in Private Equity. Finally, we share a case where advanced social media analytics enhanced competitive positioning for a leading corporation. ESG is now a critical factor in investment decision-making and value creation.

Documentation 52

Documentation 52

pharmaphorum

JUNE 30, 2021

“In recent years, we have seen encouraging signs from the large pharma companies to increase the commitment fighting climate change and to environmental, social, and corporate governance (ESG) more broadly.”. What we are seeing now is this integration between environmental health and social determinants of health.

Hospitals 98

Hospitals 98

Omnicell

JANUARY 10, 2023

We support many critical business areas, including Privacy, Ethics, Environmental, Social and Governance, Pharmacy Operations, Environmental Health and Safety, Security and Loss Prevention, Corporate Compliance, and Risk Management. Integrity is the foundation for our collective efforts in all of these areas.

Omnicell 97

Omnicell Customer Service 97

European Pharmaceutical Review

MARCH 12, 2024

Life science companies are increasingly using advanced technologies like artificial intelligence (AI), machine learning (ML) and blockchain to improve data quality and integrity by detecting anomalies in data and establishing tamper-proof audit trails for all data-related activities Data governance.

Documentation 90

Documentation Data Entry Communication Compounding 90

pharmaphorum

AUGUST 5, 2022

DE&I also forms part of the broader environmental, social and governance (ESG) performance, which has emerged as a critical yardstick for how consumers and investors view pharma companies. Image by Gino Crescoli from Pixabay .

98

98

European Pharmaceutical Review

JULY 21, 2023

There is an increasing focus on sustainability and Environmental, Social, and Governance (ESG) factors in supply chain management. Companies are expected to prioritise environmental sustainability, social responsibility, and ethical practices.

Vaccines 96

Vaccines FDA Communication Hospitals 96

Pharma Marketing Network

JANUARY 27, 2022

Key topics will include trends in Digital Health and Health Data Science, Personalized & Precision Medicine, and the impact of Environmental, Social & Governance factors on financial trends in healthcare. Impact of Environmental, Social & Corporate Governance on Financial Health.

52

52

Pharma Marketing Network

JANUARY 27, 2022

Key topics will include trends in Digital Health and Health Data Science, Personalized & Precision Medicine, and the impact of Environmental, Social & Governance factors on financial trends in healthcare. Impact of Environmental, Social & Corporate Governance on Financial Health.

52

52

pharmaphorum

APRIL 1, 2022

The webinar will also cover: Up to date analysis of political, economic, social, technological, environmental, and legal factors surrounding the new legislation. So, what are the key elements that decision-makers need to address in order to develop successful future strategies? Key issues keeping pharma and ICS awake at night.

98

98

pharmaphorum

DECEMBER 22, 2021

A group of 15 digital health startups have joined a programme set up by the US federal government to address health inequality and mitigate the effects if the COVID-19 pandemic.

Vaccines 120

Vaccines 120

pharmaphorum

JUNE 29, 2021

Digital technologies and AI are already being deployed to improve the speed and accuracy of diagnosis and screening for diseases, assist with clinical care, support R&D, and guide public health policy, according to a just-published WHO document called Ethics and governance of artificial intelligence for health.

Documentation 64

Documentation 64

Pharmaceutical Technology

AUGUST 11, 2022

The transition of focus to DPIs could serve as an efficient way for pharma companies to meet environmental, social, and corporate governance (ESG) targets. Some pharma companies, such as AstraZeneca and GSK, have started to introduce low carbon alternatives for the propellant used in pMDIs.

64

64